Perinatal Epidermal Growth Factor Receptor Blockade Prevents Peripheral Nerve Disruption in a Mouse Model Reminiscent of Benign World Health Organization Grade I Neurofibroma
- 1 May 2006
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 168 (5) , 1686-1696
- https://doi.org/10.2353/ajpath.2006.050859
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Brain Lipid Binding Protein in Axon-Schwann Cell Interactions and Peripheral Nerve TumorigenesisMolecular and Cellular Biology, 2003
- Restoring Apoptosis in Pancreatic Cancer Cells by Targeting the Nuclear Factor-κB Signaling Pathway With the Anti-Epidermal Growth Factor Antibody IMC-C225Journal of Gastrointestinal Surgery, 2003
- Mouse Models of Tumor Development in Neurofibromatosis Type 1Science, 1999
- Aberrant Cutaneous Expression of the Angiogenic Factor Midkine is Associated with Neurofibromatosis Type-1Journal of Investigative Dermatology, 1999
- Epidemiology of neurofibromatosis type 1American Journal of Medical Genetics, 1999
- Confirmation of a Double-Hit Model for the NF1Gene in Benign NeurofibromasAmerican Journal of Human Genetics, 1997
- The Growth Regulation of Neurofibroma Cells in Neurofibromatosis Type-1: Increased Responses to PDGF-BB and TGF-β1Biochemical and Biophysical Research Communications, 1994
- Mast cell numbers in melanocytic naevi and cutaneous neurofibromas.Journal of Clinical Pathology, 1993
- Effects of several growth factors on cultured neurofibroma cellsJournal of Dermatological Science, 1992
- Signal transduction by receptors with tyrosine kinase activityPublished by Elsevier ,1990